Skip to main content

What the FDA labels say about taking them together

Fluoxetine and glyburide

Glyburide's FDA label of July 1, 2021 names fluoxetine in its drug interactions section; the fluoxetine label PlainMeds reads does not name glyburide.

Check it at the source: the fluoxetine FDA label on DailyMed (effective January 8, 2026, Dista Products Company); the glyburide FDA label on DailyMed (effective July 1, 2021, TEVA Pharmaceuticals USA Inc).

What does the fluoxetine label say about glyburide?

Fluoxetine's label (effective January 8, 2026) does not name glyburide in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Prozac), NDA018936 (Eli Lilly And Co), as published by Dista Products Company, effective January 8, 2026 (SPL set c88f33ed-6dfb-4c5e-bc01-d8e36dd97299), via openFDA; the full label on DailyMed

What does the glyburide label say about fluoxetine?

Glyburide label, drug interactions

Drug Interactions The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, ACE inhibitors, disopyramide, fluoxetine, clarithromycin, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, monoamine oxidase inhibitors, and beta adrenergic blocking agents.

Source: FDA drug label (Glyburide), NDA017532 (Sanofi Aventis Us), as published by TEVA Pharmaceuticals USA Inc, effective July 1, 2021 (SPL set 50d16f1d-c814-4411-8749-62561321ecce), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

58Fluoxetine generic labelers
16Glyburide generic labelers
FluoxetineGlyburide
Labeled forDepression, Anxiety, Bipolar disorderType 2 diabetes
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0519 per capsule 40 mg capsule$0.0643 per tablet 5 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?